Daily News & Analysis | Drug is a first to help patients with melanoma of the eye Daily News & Analysis But Carvajal said he hopes patients can benefit from clinical trials until then. The team is working with AstraZeneca on plans for a follow-up study to confirm the findings for selumetinib, which the company has been studying as a treatment thyroid and ... |
